Quo-Lab meets strict international quality targets – confirming it fit for purpose for diabetes testing The study aimed to evaluate the four POC HbA1c instruments according to Clinical and Laboratory ...
Accurate diagnosis and effective management of diabetes are essential for optimizing patient outcomes and preventing complications. Hemoglobin A1c (HbA1c) testing plays a central role in assessing and ...
EKF Diagnostics, the global in vitro diagnostics company, announces that a recent study has confirmed that its Quo-Test® A1c point-of-care testing (POCT) analyzer shows comparable performance to a lab ...
Diabetes Mellitus has become a worldwide epidemic, affecting approximately 425 million people. Unfortunately, one in two patients remains undiagnosed. HbA1c can play a major role in finding these ...
EKF Diagnostics has announced that its Quo-Lab HbA1c point-of-care analyzer has successfully achieved International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) certification. The ...
EKF Diagnostics has announced that in a newly published paper [1] its Quo-Test® point-of-care (POC) hemoglobin A1c (HbA1c) analyzer has again been confirmed to meet International Federation of ...
Novel approach analyzes thousands of red blood cells from a small sample, showcasing the long-term potential of microfluidics for testing across conditions Using advanced microfluidic technology, our ...
Dublin, March 16, 2023 (GLOBE NEWSWIRE) -- The "Hemoglobin A1C (HbA1C) Testing: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback